ArticleClinical rheumatology2026

Biological/targeted synthetic disease-modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis.

Masahiro Tada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.